TippingPoint Biosciences
TippingPoint Biosciences61About
What does TippingPoint Biosciences do?
TippingPoint Biosciences is a biotechnology company focused on discovering and developing innovative antibody-based therapeutics for cancer. Their approach leverages advanced platform technologies to identify and engineer antibodies with enhanced efficacy and safety profiles. The company aims to address unmet needs in various oncology indications.
What is TippingPoint Biosciences's revenue?
StartupHub estimates TippingPoint Biosciences's annual revenue at $1.6M (range $1.1M to $3.6M, 65% confidence), based on comparable companies in the sector.
What is TippingPoint Biosciences's valuation?
StartupHub estimates TippingPoint Biosciences's effective valuation at $1.1B (range $746.3M to $1.4B, 39% confidence), based on comparable companies in the sector.
How much funding has TippingPoint Biosciences raised?
TippingPoint Biosciences has raised a total of $15M in funding. The most recent round on record is Seed.
Where is TippingPoint Biosciences headquartered?
TippingPoint Biosciences is headquartered in Cambridge, Massachusetts, USA.
When was TippingPoint Biosciences founded?
TippingPoint Biosciences was founded in 2021.
What industry does TippingPoint Biosciences operate in?
TippingPoint Biosciences operates in Biotech, Drug Discovery, Antibody Therapeutics, Oncology, Genomics, Therapeutics.
How many employees does TippingPoint Biosciences have?
TippingPoint Biosciences has approximately 7 people on record.
What is TippingPoint Biosciences's current status?
TippingPoint Biosciences's current operating status is: Inactive.
No comments yet. Be the first to share your take.